Introduction
Pulmonary embolism is a blockage of one or more arteries in the lungs, usually caused by a blood clot that has traveled to the pulmonary circulation from elsewhere in the body. The condition primarily involves the pulmonary arteries, the right side of the heart, and the lung tissue supplied by the blocked vessel. Its defining biological feature is a sudden interruption of blood flow through the pulmonary vascular system, which alters gas exchange, increases pressure on the heart, and can impair oxygen delivery throughout the body.
In most cases, pulmonary embolism begins as a clot in a deep vein, commonly in the legs or pelvis. That clot can detach, travel through the venous system, pass through the right side of the heart, and lodge in the pulmonary arteries. Once there, it narrows or completely obstructs blood flow to part of the lung. The result is not simply a clot sitting in a vessel; it is a dynamic disturbance of circulation, pressure, ventilation-perfusion matching, and right ventricular workload.
The Body Structures or Systems Involved
The main structures involved in pulmonary embolism are the deep veins, the right atrium and right ventricle, the pulmonary arteries, and the lung regions they supply. The blood clot often originates in the deep venous system of the legs, where blood flow is slower and clot formation is more likely under certain conditions. From there, the clot can move through the inferior vena cava to the right heart and then into the pulmonary arteries.
The pulmonary circulation has a specialized role. It receives deoxygenated blood from the right ventricle and carries it through progressively smaller arteries and capillaries around the air sacs of the lungs. In healthy physiology, this circuit allows carbon dioxide to be released and oxygen to enter the blood. The resistance within this circulation is normally low, which lets the right ventricle pump blood without much strain.
The right ventricle is especially relevant because it is adapted to handle a low-pressure system. When a clot blocks part of the pulmonary arterial tree, the right ventricle suddenly faces higher resistance. Unlike the left ventricle, it is not built to generate large pressures for sustained periods. This makes the heart a central participant in the effects of pulmonary embolism.
The condition also involves the relationship between airflow and blood flow in the lungs. The lungs must receive both ventilation and perfusion for efficient gas exchange. A pulmonary embolus disrupts perfusion without directly blocking ventilation, producing areas of the lung that are aired but not adequately supplied with blood. This mismatch is a core physiological feature of the disorder.
How the Condition Develops
Pulmonary embolism usually develops through a sequence of events known as venous thromboembolism. A clot forms in a vein, most often because blood flow has slowed, the vessel wall has been injured, or the blood has become more prone to clotting. These factors are often grouped as Virchow’s triad: stasis, endothelial injury, and hypercoagulability. A clot that forms under these conditions may remain attached, but part of it can break free and become an embolus.
Once detached, the embolus is carried by venous blood toward the lungs. It passes through large veins and the right side of the heart before entering the pulmonary arterial circulation. The size of the embolus determines how far it travels. Large clots may block the main pulmonary artery or a major branch, while smaller ones may reach segmental or subsegmental vessels. In either case, the embolus reduces or stops blood flow beyond the point of obstruction.
The immediate consequence is mechanical blockage. Blood cannot reach the capillary bed in the affected area of lung, so gas exchange at that region is reduced or absent. At the same time, the body may still continue ventilating that lung tissue, which creates ventilated but underperfused alveoli. This mismatch lowers the efficiency of oxygen uptake and can contribute to low arterial oxygen levels, especially when the obstruction is extensive.
Physiologically, the body responds to the sudden rise in pulmonary vascular resistance by increasing right ventricular pressure. If the embolus is large or numerous, the right ventricle may dilate and struggle to maintain forward flow. Reduced output from the right ventricle lowers blood return to the left side of the heart, which can decrease systemic circulation and blood pressure. In severe cases, this can produce obstructive shock.
The blocked vessel also triggers local biologic responses. Platelets and clotting factors within the embolus remain active for a period, and the vessel wall may react with vasoconstriction and inflammatory signaling. These changes can further elevate resistance in the pulmonary arteries beyond the physical blockage itself. The surrounding lung tissue may remain structurally intact at first, but it becomes functionally compromised because perfusion is interrupted.
Structural or Functional Changes Caused by the Condition
The most direct change is occlusion of the pulmonary arterial lumen. This limits blood flow to part of the lung and creates areas that are ventilated but not effectively perfused. The result is inefficient gas exchange, because the air reaching the alveoli cannot be matched by enough blood in the capillaries to pick up oxygen and remove carbon dioxide.
Another key change is increased pressure in the pulmonary circulation. Even partial obstruction raises resistance to blood flow, and the right ventricle must work harder to move blood through the lungs. If the load is substantial, the ventricle can stretch and become less effective at pumping. This right-sided strain can reduce the amount of blood reaching the left heart, which lowers cardiac output.
At the tissue level, portions of lung supplied by the blocked vessel may become underperfused. The lung has some dual blood supply from the bronchial circulation, so complete infarction is less common than in other organs. However, if obstruction is severe and collateral flow is inadequate, small areas of pulmonary infarction can occur. These areas may undergo tissue injury because oxygen delivery is insufficient.
The condition can also alter blood chemistry and respiratory control. Reduced oxygen transfer may lead to hypoxemia, which stimulates increased breathing. The body may respond with faster, deeper respiration in an attempt to improve oxygenation and reduce carbon dioxide levels. This response does not correct the underlying vascular blockage, but it reflects the body’s attempt to compensate for the disturbed physiology.
In larger emboli, the circulatory effects can extend beyond the lungs. A sharp reduction in right ventricular output can cause systemic hypotension, reduced organ perfusion, and metabolic stress. Thus pulmonary embolism is not limited to a lung vessel problem; it can become a whole-circulation disorder through its effects on heart function and oxygen delivery.
Factors That Influence the Development of the Condition
The likelihood of pulmonary embolism depends largely on conditions that promote clot formation in the venous system. Immobility slows venous return, especially in the deep veins of the legs, allowing clotting factors to accumulate. This is one of the most important mechanical influences because the venous system depends on muscle movement and valve function to keep blood flowing steadily back to the heart.
Endothelial injury is another major influence. Damage to the lining of veins can expose tissue factors and alter the local balance between clot formation and clot breakdown. Surgery, trauma, and inflammation can all disrupt this lining and increase the likelihood that a clot will form and persist.
Hypercoagulability refers to a state in which the blood is more prone to clot than usual. This may arise from inherited changes in coagulation proteins, acquired disorders, hormonal influences, malignancy, pregnancy, or certain medications. In these settings, clotting pathways are more easily activated or less effectively regulated. The result is a greater chance that a deep venous clot will develop and later embolize.
Systemic illness can also shape risk by altering circulation and coagulation. Cancer, for example, can increase clotting activity through tumor-related release of procoagulant substances and inflammation. Inflammatory states may change platelet behavior, endothelial function, and fibrinolysis, all of which can shift the balance toward thrombosis.
Age and body composition can influence venous flow and clotting tendencies, partly by affecting mobility, venous pressure, and vascular biology. Genetic factors may contribute through inherited changes in clotting factor regulation. These influences do not cause pulmonary embolism by themselves, but they can create a physiological environment in which venous thrombosis is more likely.
Variations or Forms of the Condition
Pulmonary embolism varies according to the size of the clot, the number of vessels involved, and the speed with which it develops. A massive embolism may block a major pulmonary artery and cause sudden, severe hemodynamic compromise. A smaller embolus may obstruct only a segmental branch and produce a more limited disturbance in blood flow. The same basic mechanism applies in both cases, but the physiologic impact differs according to the amount of lung and vascular territory affected.
The condition may also be classified as acute or recurrent. An acute embolism appears suddenly when a clot travels to the lungs and lodges there. Recurrent embolism occurs when multiple clots reach the pulmonary arteries over time. Repeated events can gradually alter the pulmonary circulation, right ventricular workload, and lung perfusion patterns.
Another variation concerns the location of obstruction. Central emboli affect large proximal arteries and tend to have more pronounced hemodynamic effects. Peripheral emboli occur in smaller branches and may have a more limited impact on blood pressure but can still produce significant ventilation-perfusion mismatch if numerous.
There are also differences in the underlying material that blocks the vessel. Most emboli are thrombotic, but in uncommon cases fat, air, amniotic fluid, or tumor fragments can obstruct the pulmonary circulation. These non-thrombotic emboli differ in origin, but they share the same essential feature: they interfere with pulmonary blood flow and disrupt the normal function of the lung vasculature.
How the Condition Affects the Body Over Time
If the embolus is not rapidly cleared or if additional emboli continue to arrive, the pulmonary circulation may remain under strain. Persistent obstruction can keep pulmonary vascular resistance elevated, forcing the right ventricle to work against a sustained pressure load. Over time, this can lead to right ventricular enlargement and reduced pumping efficiency.
Repeated or unresolved obstruction can also produce chronic changes in the lung vasculature. In some cases, the clot becomes organized into fibrous tissue rather than fully dissolving. This can leave persistent narrowing or blockage of pulmonary vessels and impair blood flow long after the original event. If enough vascular territory is affected, the body may develop chronic elevation of pulmonary arterial pressure.
Long-standing obstruction can therefore contribute to pulmonary hypertension and chronic strain on the right heart. The heart may initially compensate by increasing force of contraction, but compensation has limits. As the burden continues, the right ventricle may weaken, and systemic circulation may be affected. This is one reason why an embolic event can have consequences beyond the acute phase.
The lung tissue itself may also adapt to altered perfusion. Regions with reduced blood flow may receive less effective exchange of gases, and the body may recruit collateral blood supply where possible. However, these adaptations are often incomplete. The balance between ventilation and perfusion can remain disturbed, particularly when emboli are recurrent or extensive.
In the long term, the most important concept is that pulmonary embolism is not a static blockage. It can resolve, recur, organize into scar-like material, or contribute to chronic vascular disease. Its course depends on the size and number of emboli, the body’s ability to break down clot, and the extent to which the right heart can tolerate the increased resistance.
Conclusion
Pulmonary embolism is a vascular disorder in which a clot or other material blocks blood flow in the pulmonary arteries. It usually begins as venous thrombosis elsewhere in the body, then travels through the right side of the heart into the lung circulation. The condition disrupts pulmonary perfusion, creates ventilation-perfusion mismatch, raises resistance in the pulmonary arteries, and can strain the right ventricle.
Understanding pulmonary embolism means understanding the interaction between clot formation, venous transport, pulmonary blood flow, and cardiac response. The condition is defined not only by the presence of an embolus, but by the physiological cascade that follows when blood can no longer move normally through the lungs. That cascade explains why pulmonary embolism can range from a limited vascular blockage to a life-threatening disturbance of circulation and gas exchange.